TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Dating Sites: Best, Worst & Weirdest
PERSONAL FINANCE

10 Cities Unaffected by a Bad Economy

  • By Jason Notte
  • Aug 8, 2011 12:30 PM EDT
Google's Android Pay Takes Aim at Apple Pay
PERSONAL FINANCE

10 Cities Unaffected by a Bad Economy

  • By Jason Notte
  • May 9, 2011 8:30 AM EDT
Dating Sites: Best, Worst & Weirdest
STOCKS

BlackRock Trades Heavy on Index Inclusion

  • By Michael Baron
  • Apr 1, 2011 5:12 PM EDT
February 27 Premarket Briefing: 10 Things You Should Know
MARKETS

Stocks Finish Higher on Jobs Outlook, Small-Cap Rally

  • By Shanthi Bharatwaj
  • Mar 30, 2011 4:29 PM EDT
Dating Sites: Best, Worst & Weirdest
OPINION

10 Stocks to Watch: Align, Apollo

  • By Andrea Tse
  • Mar 30, 2011 4:20 PM EDT
3 Hold-Rated Dividend Stocks: GHL, OKS, OAK
MARKETS

Genzyme Stock Hits New 52-Week High (GENZ)

  • By TheStreet Wire
  • Mar 30, 2011 10:06 AM EDT
Perilous Reversal Watch: Yamana Gold (AUY)
MARKETS

Genzyme Stock Hits New 52-Week High (GENZ)

  • By TheStreet Wire
  • Mar 3, 2011 2:52 PM EST
New York Slideshow: 9/11 and After
STOCKS

10 Top Hedge Fund Stock Buys

  • By Shanthi Bharatwaj
  • Feb 25, 2011 12:56 PM EST
Galapagos Receives a Rousing Welcome on Its First Day of Trading
STOCKS

Biotech Calendar: 2011 FDA Drug Approvals

  • By Adam Feuerstein
  • Feb 22, 2011 7:36 AM EST
Markets Finish at Multiyear Highs
MARKETS

Markets Finish at Multiyear Highs

  • By Shanthi Bharatwaj
  • Feb 16, 2011 4:37 PM EST
3 Basic Materials Stocks Driving The Sector Higher
MARKETS

Genzyme Stock Hits New 52-Week High (GENZ)

  • By TheStreet Wire
  • Feb 16, 2011 9:54 AM EST
The Royal Wedding: Photo Slideshow
MARKETS

Futures Up on Rising Housing Starts, Dell

  • By Melinda Peer
  • Feb 16, 2011 9:00 AM EST
Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie
STOCKS

Borders, Comcast: Premarket Trading

  • By Andrea Tse
  • Feb 16, 2011 8:01 AM EST
First-Quarter Sales of Bristol-Myers' Cancer Immunotherapy Drug Miss Street Forecast
STOCKS

Sanofi to Buy Genzyme for $20.1 Billion

  • By Joseph Woelfel
  • Feb 16, 2011 4:22 AM EST
Today's Weak On High Volume Stock: Ocean Rig UDW (ORIG)
MARKETS

Genzyme Rises On Unusually High Volume (GENZ)

  • By TheStreet Wire
  • Feb 15, 2011 3:52 PM EST
CTI Biopharma Posts Positive Myelofibrosis Study Results
STOCKS

Sanofi's Buy of Genzyme Imminent: Report

  • By Theresa McCabe
  • Feb 15, 2011 1:57 PM EST
January 2 Premarket Briefing: 10 Things You Should Know
MARKETS

Egypt's Next Steps Key in Coming Week

  • By Shanthi Bharatwaj
  • Feb 13, 2011 4:27 AM EST
Why Raptor Is Down, Despite Possibility of New Drug Approval
STOCKS

Large Biotechs: Getting Old, Breaking Down

  • By Adam Feuerstein
  • Feb 9, 2011 6:45 AM EST
Furiex Pharma Diarrhea Drug Produces Solid Results in Pivotal Studies
STOCKS

Sanofi Profits Fall; Mum on Genzyme

  • By Joseph Woelfel
  • Feb 9, 2011 4:54 AM EST
DISH Attractive Despite Losing Clearwire, Macquarie Says
STOCKS

Ensco to Buy Pride: Premarket Trading

  • By Andrea Tse
  • Feb 7, 2011 8:32 AM EST
Horizon Goes Hostile With $3 Billion Takeout Offer for Depomed
STOCKS

Sanofi, Genzyme Work Toward Deal

  • By TheStreet Staff
  • Feb 6, 2011 4:20 PM EST
Stocks Are Slightly Lower as First-Quarter GDP, Chicago PMI Decline
MARKETS

Stocks Lifted by Energy Sector Rally

  • By Shanthi Bharatwaj
  • Jan 31, 2011 4:43 PM EST
FDA Tells Delcath No Approval Without New Clinical Trial
STOCKS

Sanofi, Genzyme Agree on Merger Outline

  • By Joseph Woelfel
  • Jan 31, 2011 1:05 PM EST
AbbVie Deserves More Respect
STOCKS

Biotech Calendar: Key Dates for February

  • By Adam Feuerstein
  • Jan 31, 2011 9:10 AM EST
AbbVie Deserves More Respect
STOCKS

Amgen: 2011 Financial Guidance Preview

  • By Adam Feuerstein
  • Jan 24, 2011 9:33 AM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.